| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 657.25M | 1.05B | 1.06B | 1.06B | 1.23B | 603.86M |
| Gross Profit | 430.67M | 638.20M | 471.67M | 705.45M | 904.40M | 439.66M |
| EBITDA | 195.69M | 336.49M | 251.95M | 208.22M | 628.49M | 380.53M |
| Net Income | -123.47M | -94.84M | -655.88M | -295.97M | -8.11M | -233.24M |
Balance Sheet | ||||||
| Total Assets | 9.57B | 10.12B | 10.53B | 13.31B | 16.02B | 17.96B |
| Cash, Cash Equivalents and Short-Term Investments | 391.01M | 495.85M | 583.23M | 908.79M | 1.15B | 1.71B |
| Total Debt | 3.44B | 4.26B | 3.98B | 5.30B | 6.16B | 8.05B |
| Total Liabilities | 4.41B | 4.86B | 5.07B | 6.89B | 8.72B | 10.77B |
| Stockholders Equity | 4.24B | 4.34B | -61.57M | 5.11B | 5.41B | 5.39B |
Cash Flow | ||||||
| Free Cash Flow | 82.62M | 341.79M | 615.39M | 554.98M | 261.71M | -176.71M |
| Operating Cash Flow | 86.62M | 451.57M | 631.22M | 639.61M | 386.25M | -85.98M |
| Investing Cash Flow | -37.83M | -25.44M | 722.69M | 1.37B | 624.09M | 512.72M |
| Financing Cash Flow | -170.71M | -492.28M | -1.69B | -2.05B | -1.35B | -238.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | HK$50.87M | 4.26 | 12.66% | ― | 64.51% | 104.35% | |
57 Neutral | HK$166.42M | 8.13 | 3.56% | ― | 38.96% | 700.00% | |
44 Neutral | HK$136.65M | -0.75 | ― | ― | -22.77% | 40.53% | |
42 Neutral | HK$523.08M | -4.65 | -20.26% | ― | -166.78% | 85.53% | |
41 Neutral | HK$39.43M | -0.05 | -53.23% | ― | -26.78% | -166.41% |
Gemini Investments (Holdings) Limited has announced a major transaction involving the sale of properties in the U.S. through its real estate fund platform. The transaction, valued at approximately US$30 million, is considered a major transaction under Hong Kong’s Listing Rules, requiring shareholder approval. The company plans to obtain written approval from major shareholders, potentially exempting it from convening a general meeting. This move is expected to streamline the approval process and align with regulatory requirements.